Dazucorilant 300 mg clinical trials

Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

This study is looking at a new medication, dazucorilant, for people with Amyotrophic Lateral Sclerosis (ALS). Researchers want to see if it's safe and helps improve symptoms. It involves different doses and aims to understand how the drug works and how well it's tolerated by patients.